Topical ocular antibiotics induce bacterial resistance at extraocular sites

B D Gaynor1, J D Chidambaram, V Cevallos

  • 1Department of Ophthalmology, F I Proctor Foundation, 95 Kirkham Street, Room 307, University of California San Francisco, San Francisco, CA 94143-0944, USA.

Insights

Mass antibiotic treatments for trachoma control can increase drug-resistant Streptococcus pneumoniae. Both oral azithromycin and topical tetracycline showed increased resistance, suggesting topical antibiotics impact nasopharyngeal bacterial resistance.

Area of Science:

  • Medical Microbiology
  • Public Health
  • Infectious Diseases

Background:

  • Trachoma control programs often utilize mass antibiotic administration.
  • The impact of these treatments on nasopharyngeal bacterial resistance, particularly Streptococcus pneumoniae, is not fully understood.
  • Understanding resistance patterns is crucial for effective antibiotic stewardship.

Purpose of the Study:

  • To compare antibiotic resistance in nasopharyngeal Streptococcus pneumoniae.
  • To assess resistance following topical tetracycline or systemic azithromycin treatment for trachoma.
  • To evaluate the effect of mass antibiotic administration on antibiotic resistance.

Main Methods:

  • Children (1-10 years) in trachoma-endemic villages received annual oral azithromycin or topical tetracycline for 3 years.
  • Nasopharyngeal carriage of S. pneumoniae was surveyed 6 months after the third treatment.
  • Antibiotic resistance was determined using broth dilution MIC technique.

Main Results:

  • S. pneumoniae carriage rates were similar across treated and untreated villages.
  • Antibiotic resistance patterns differed significantly between treatment groups (p=0.004).
  • Topical tetracycline treatment correlated with higher tetracycline resistance (p=0.010), while oral azithromycin correlated with higher macrolide resistance (p=0.014).

Conclusions:

  • Annual mass oral azithromycin treatment can alter the prevalence of drug-resistant S. pneumoniae.
  • Topical tetracycline treatment may also increase nasopharyngeal pneumococcal resistance.
  • Topical antibiotic use could potentially influence extraocular bacterial resistance patterns.
Abstract

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...